งานวิจัย 10 อันดับที่ถูกอ้างอิงมากที่สุด | คณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล

Top-10 Most Cited Articles- Faculty of Medicine Ramathibodi Hospital, Mahidol University

Document title	Authors	Year	Source	Cited by
1. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: A case-control study	Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M.G., Commerford, P., Lang, C.C., Rumboldt, Z., Onen, C.L., Lisheng, L., Tanomsup, S., Wangai Jr., P., Razak, F., Sharma, A.M., Anand, S.S.	2005	Lancet, 366 (9497) , pp. 1640-1649.	1899
2. A new approach for catheter ablation of atrial fibrillation: Mapping of the electrophysiologic substrate	Nademanee, K., McKenzie, J., Kosar, E., Schwab, M., Sunsaneewitayakul, B., Vasavakul, T., Khunnawat, C., Ngarmukos, T.	2004	Journal of the American College of Cardiology, 43 (11) , pp. 2044-2053.	1513
3. Sarcopenia in Asia: Consensus report of the Asian working group for sarcopenia	Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K.S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., Lee, J.S.W., Lee, W.-J., Lee, Y., Liang, C.-K., Limpawattana, P., Lin, C.-S., Peng, L.-N., Satake, S., Suzuki, T., Won, C.W., Wu, C.-H., Wu, S.-N., Zhang, T., Zeng, P., Akishita, M., Arai, H.	2014	Journal of the American Medical Directors Association, 15 (2) , pp. 95-101.	1008
4. Effect of nesiritide in patients with acute decompensated heart failure	O'Connor C.M., Starling R.C., Hernandez A.F., Armstrong P.W., Dickstein K., Hasselblad V., Heizer G.M., (...), Califf R.M.	2011	New England Journal of Medicine, 365 (1) , pp. 32-43.	812
5. Dronedarone in high-risk permanent atrial fibrillation	Connolly S.J., Camm A.J., Halperin J.L., Joyner C., Alings M., Amerena J., Atar D., (...), Yunus A.	2011	New England Journal of Medicine, 365 (24) , pp. 2268-2276.	436
6. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: A multicentre, randomised, double-blind phase 3 trial	San-Miguel J.F., Hungria V.T.M., Yoon S.-S., Beksac M., Dimopoulos M.A., Elghandour A., Jedrzejczak W.W., (...), Richardson P.G.	2014	The Lancet Oncology, 15 (11) , pp. 1195-1206.	424
7. Prevention of ventricular fibrillation episodes in brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium	Nademanee, K., Veerakul, G., Chandanamattha, P., Chaothawee, L., Ariyachaipanich, A., Jirasirirojanakorn, K., Likittanasombat, K., Bhuripanyo, K., Ngarmukos, T.	2011	Circulation, 123 (12) , pp. 1270-1279.	403
8. Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: Results from the randomized phase III BRISK-FL study	Johnson, P.J., Qin, S., Park, J.-W., Poon, R.T.P., Raoul, J.-L., Philip, P.A., Hsu, C.-H., Hu, T.-H., Heo, J., Xu, J., Lu, L., Chao, Y., Boucher, E., Han, K.-H., Paik, S.-W., Robles-Aviña, J., Kudo, M., Yan, L., Sobhonslidsuk, A., Komov, D., Decaens, T., Tak, W.-Y., Jeng, L.-B., Liu, D., Ezzeddine, R., Walters, I., Cheng, A.-L.	2013	Journal of Clinical Oncology, 31 (28) , pp. 3517-3524.	388
9. Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: A randomized phase 2 trial	Kantarjian, H., Pasquini, R., Hamerschlak, N., Rousselot, P., Holowiecki, J., Jootar, S., Robak, T., Khoroshko, N., Masszi, T., Skotnicki, A., Hellmann, A., Zaritsky, A., Golenkov, A., Radich, J., Hughes, T., Countouriotis, A., Shah, N.	2007	Blood, 109 (12) , pp. 5143-5150.	319
10. Vaccination greatly reduces disease, disability, death and inequity worldwide	Andre, F.E., Booy, R., Bock, H.L., Clemens, J., Datta, S.K., John, T.J., Lee, B.W., Lolekha, S., Peltola, H., Ruff, T.A., Santosham, M., Schmitt, H.J.	2008	Bulletin of the World Health Organization, 86 (2) , pp. 140-146.	310

by Scopus Update data : 9 Jan 2020